Cambridge, Massachusetts-based ImmusanT Inc, a developer of treatments for celiac disease, has secured an undisclosed amount of funding. The investor was JDRF T1D Fund.
Source: Press Release
Cambridge, Massachusetts-based ImmusanT Inc, a developer of treatments for celiac disease, has secured an undisclosed amount of funding. The investor was JDRF T1D Fund.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: